Cor Vasa 2024, 66(1):29-36 | DOI: 10.33678/cor.2023.085

Clinical Outcomes of Isolated Non-Left Main Side Branch Ostial Stenosis: Medical Therapy versus Percutaneous Coronary Intervention (the ALP-SBO registry)

Serkan Kahraman, Ahmet Guner, Fatih Uzun, Ali Kemal Kalkan, Mustafa Ali Yavas, Mehmet Cicek, Taner Sahin, Cemalettin Akman, Omer Celik, Mehmet Ertruk
University of Health Sciences, Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Center, Department of Cardiology, Training and Research Hospital, Istanbul, Turkey

Aim: Side branch (SB) ostial stenosis is a frequent bifurcation lesion and its optimal treatment strategy is still debated. Although the efficacy of the optimal medical therapy is well known, the comparison of the medical treatment and percutaneous coronary intervention (PCI) is controversial.

Methods: A total of 357 consecutive patients with isolated SB ostial stenosis (Medina 0.0.1 classification) was evaluated retrospectively. Patients were divided into two groups; patients with only medical therapy (n = 305) and patients undergoing PCI (n = 52). Target vessel revascularization (TVR), myocardial infarction (MI), and mortality were evaluated as major adverse cardiovascular outcomes (MACE).

Results: The mean age of the patients was 58.2±10.3 years. 102 patients (28.6%) were female. 279 patients (78.2%) had diagonal lesion while 78 (21.8%) had obtuse marginal lesion. The SB stenosis ratio (70±16; 88±13, p < 0.001) and SB lesion length (7.5±6.6; 14.7±6.0, p < 0.001) were higher in the PCI group. SB ostial stenting (38 patients [73.1%]) was the common PCI technique. There were no significant differences in terms of TVR (1.3%; 1.9%, p = 0.277, medical vs PCI groups, respectively), MI (8.2%; 7.7%, p = 0.302, medical vs PCI groups, respectively), mortality (10.2%; 9.6%, p = 0.095, medical vs PCI groups, respectively) and MACE (18.0%; 15.4%, p = 0.113, medical vs PCI groups, respectively) between groups. Additionally, in Kaplan-Meier long-term survival analysis, there were no differences in TVR (log-rank p = 0.247), MI (log-rank p = 0.295), mortality (log-rank p = 0.086), and MACE (log-rank p = 0.107) between groups.

Conclusions: Medical therapy instead of PCI seems to be an appropriate and optimal treatment strategy in patients with non-left main SB ostial stenosis.

Keywords: Coronary bifurcation lesion, Percutaneous coronary intervention, Ostial stenosis, Side branch,

Received: October 16, 2023; Revised: November 19, 2023; Accepted: November 21, 2023; Prepublished online: June 2, 2012; Published: March 5, 2024  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kahraman S, Guner A, Uzun F, Kalkan AK, Yavas MA, Cicek M, et al.. Clinical Outcomes of Isolated Non-Left Main Side Branch Ostial Stenosis: Medical Therapy versus Percutaneous Coronary Intervention (the ALP-SBO registry). Cor Vasa. 2024;66(1):29-36. doi: 10.33678/cor.2023.085.
Download citation

References

  1. Burzotta F, Lassen JF, Lefèvre T, et al. Percutaneous coronary intervention for bifurcation coronary lesions: the 15th consensus document from the European Bifurcation Club. EuroIntervention 2021;16:1307-1317. Go to original source... Go to PubMed...
  2. Jim MH. Shoulder technique: a modified sleeve technique devised for treating isolated coronary stenosis at side branch ostium. Int J Cardiol 2014;171:94-95. Go to original source... Go to PubMed...
  3. Brueck M, Heidt M, Kramer W, Ludwig J. Comparison of interventional versus conservative treatment of isolated ostial lesions of coronary diagonal branch arteries. Am J Cardiol 2004;93:1162-1164. Go to original source... Go to PubMed...
  4. Weinstein JM, Cafri C, Wolak A, Ilia R. Medical treatment versus angioplasty for isolated ostial diagonal stenoses: a comparative clinical follow-up. J Invasive Cardiol 2012;24:222-223.
  5. Medina A, Suárez de Lezo J, Pan M. A new classification of coronary bifurcation lesions. Rev Esp Cardiol 2006;59:183. Go to original source...
  6. Lunardi M, Louvard Y, Lefèvre T, et al. Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations. J Am Coll Cardiol 2022;80:63-88. Go to original source... Go to PubMed...
  7. Boden WE, O'Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356:1503-1516. Go to original source... Go to PubMed...
  8. Maron DJ, Hochman JS, Reynolds HR, et al. Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 2020;382:1395-1407. Go to original source... Go to PubMed...
  9. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. Eur Heart J 2019;40:87-165. Go to original source... Go to PubMed...
  10. Albiero R, Burzotta F, Lassen JF, et al. Treatment of coronary bifurcation lesions, part I: implanting the first stent in the provisional pathway. The 16th expert consensus document of the European Bifurcation Club. EuroIntervention 2022;18:e362-e376. Go to original source... Go to PubMed...
  11. Burzotta F, Lassen JF, Louvard Y, et al. European Bifurcation Club white paper on stenting techniques for patients with bifurcated coronary artery lesions. Catheter Cardiovasc Interv 2020;96:1067-1079. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.





Cor et Vasa

You are accessing a site intended for medical professionals, not the lay public. The site may also contain information that is intended only for persons authorized to prescribe and dispense medicinal products for human use.

I therefore confirm that I am a healthcare professional under Act 40/1995 Coll. as amended by later regulations and that I have read the definition of a healthcare professional.